Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Levaquin (Levofloxacin)
Company:  R.W. Johnson Pharmaceutical Research Institute
Application No.:  020634s015, s021, s022 & 020635s012, s019, s020
Approval Date: 12/18/2001


Date created: June 24, 2005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.